Literature DB >> 565677

Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links.

W E Ross, R A Ewig, K W Kohn.   

Abstract

The formation of DNA cross-links is thought to represent the lethal lesion following exposure of cells to bifunctional alkylating agents. Since differences in rates of formation and repair of cross-links may explain differences in activity of these agents, we have studied these events following exposure of L1210 cells to nitrogen mustard (HN2) and melphalan. With the technique of alkaline elution, it was possible to measure cross-linking at doses that result in relatively little cell kill. Following a 30-min exposure to HN2, DNA cross-links increased for 1 to 2 hr and were then removed by a process that was virtually complete in 24 hr. In contrast, following a 30-min exposure to melphalan, cross-link formation increased for 12 hr and removal was much slower than it was for HN2. Comparison of cell survival with cross-linking kinetics suggests that persistence of the cross-links with time is an important factor in determining lethality.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 565677

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells.

Authors:  K B Tan; M R Mattern; R A Boyce; P S Schein
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Mechlorethamine-induced DNA-protein cross-linking in human fibrosarcoma (HT1080) cells.

Authors:  Erin D Michaelson-Richie; Xun Ming; Simona G Codreanu; Rachel L Loeber; Daniel C Liebler; Colin Campbell; Natalia Y Tretyakova
Journal:  J Proteome Res       Date:  2011-04-29       Impact factor: 4.466

3.  A rationally designed genotoxin that selectively destroys estrogen receptor-positive breast cancer cells.

Authors:  Kaushik Mitra; John C Marquis; Shawn M Hillier; Peter T Rye; Beatriz Zayas; Annie S Lee; John M Essigmann; Robert G Croy
Journal:  J Am Chem Soc       Date:  2002-03-06       Impact factor: 15.419

4.  Strategic down-regulation of DNA polymerase beta by antisense RNA sensitizes mammalian cells to specific DNA damaging agents.

Authors:  J K Horton; D K Srivastava; B Z Zmudzka; S H Wilson
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

5.  Increased cancericidal activity of PTT.119; a new synthetic bis-(2-chloroethyl)amino-L-phenylalanine derivative with carrier amino acids. II. In vivo bioassay.

Authors:  M J Yagi; M Zanjani; J F Holland; J G Bekesi
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

Review 6.  Hypoxia and drug resistance.

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

7.  Persistence of chromosome rearrangements in peripheral lymphocytes from patients treated with melphalan for ovarian carcinoma.

Authors:  B Lambert; K Holmberg; N Einhorn
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

8.  Proteomic analysis of DNA-protein cross-linking by antitumor nitrogen mustards.

Authors:  Rachel L Loeber; Erin D Michaelson-Richie; Simona G Codreanu; Daniel C Liebler; Colin R Campbell; Natalia Y Tretyakova
Journal:  Chem Res Toxicol       Date:  2009-06       Impact factor: 3.739

9.  Specificity and kinetics of interstrand and intrastrand bifunctional alkylation by nitrogen mustards at a G-G-C sequence.

Authors:  G B Bauer; L F Povirk
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

10.  Variability of tumor response to chemotherapy. II. Contribution of tumor heterogeneity.

Authors:  L Simpson-Herren; P E Noker; S D Wagoner
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.